Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
01 1Granules India Ltd
02 1AX Pharmaceutical Corp
03 1Aurobindo Pharma Limited
04 1DARMERICA, LLC
05 1Hetero Labs Limited
06 1MAEDA INC
07 3MSN Laboratories Private Limited
08 1Natco Pharma Limited
09 1Yabao Pharmaceutical Group Co., Ltd.
01 2SORAFENIB
02 2Sorafenib
03 5Sorafenib Tosylate
04 1Sorafenib Tosylate (form-I)
05 1sorafenib tosylate
01 1Canada
02 7India
03 1U.S.A
04 2Blank
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-982
Start Marketing Date : 2023-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-649
Start Marketing Date : 2024-01-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 73377-277
Start Marketing Date : 2024-05-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 71052-675
Start Marketing Date : 2021-04-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0073
Start Marketing Date : 2005-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0127
Start Marketing Date : 2024-05-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0034
Start Marketing Date : 2015-02-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0089
Start Marketing Date : 2019-03-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63850-8051
Start Marketing Date : 2016-01-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69262-0002
Start Marketing Date : 2022-11-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Sorafenib Tosylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sorafenib Tosylate, including repackagers and relabelers. The FDA regulates Sorafenib Tosylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sorafenib Tosylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sorafenib Tosylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sorafenib Tosylate supplier is an individual or a company that provides Sorafenib Tosylate active pharmaceutical ingredient (API) or Sorafenib Tosylate finished formulations upon request. The Sorafenib Tosylate suppliers may include Sorafenib Tosylate API manufacturers, exporters, distributors and traders.
click here to find a list of Sorafenib Tosylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sorafenib Tosylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sorafenib Tosylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sorafenib Tosylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sorafenib Tosylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sorafenib Tosylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sorafenib Tosylate suppliers with NDC on PharmaCompass.
We have 7 companies offering Sorafenib Tosylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
